Your browser doesn't support javascript.
loading
Effectiveness and safety of different amifostine regimens: Preliminary results of a phase II multicenter randomized controlled trial.
Chang, Hui; Yi, Wei; Wang, Xiaohui; Tao, Yalan; Yang, Xin; Chen, Chen; Zhang, Wenwen; Zhou, Shu; Liu, Songran; Li, Xiaohui; Ding, Shirong; Li, Jing; Li, Gong; Shao, Xunfan; Liu, Yimin; Song, Weishu; Xia, Yunfei.
  • Chang H; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou 510060, China.
  • Yi W; Department of Radiation Oncology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
  • Wang X; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou 510060, China.
  • Tao Y; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou 510060, China.
  • Yang X; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou 510060, China.
  • Chen C; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou 510060, China.
  • Zhang W; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou 510060, China.
  • Zhou S; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou 510060, China.
  • Liu S; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou 510060, China.
  • Li X; Department of Oncology, People's Liberation Army 421 Hospital, Guangzhou 510318, China.
  • Ding S; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou 510060, China.
  • Li J; Department of Oncology, the Main Guangzhou Hospital of the Guangzhou Military Region, Guangzhou 510010, China.
  • Li G; Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510530, China.
  • Shao X; Department of Radiation Oncology, the Affiliated Cancer Hospital of Guangzhou Medical College, Guangzhou 510095, China.
  • Liu Y; Department of Radiation Oncology, the Second Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510120, China.
  • Song W; Department of Oncology, Guangdong Second People's Hospital, Guangzhou 510317, China.
  • Xia Y; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou 510060, China.
Chin J Cancer Res ; 30(3): 307-314, 2018 Jun.
Article en En | MEDLINE | ID: mdl-30046225

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Año: 2018 Tipo del documento: Article